CannabisNewsBreaks Archive - Page 26 of 429

ThursdayMay 11, 2023 2:55 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced completion of batch manufacturing of the DehydraTECH(TM)-processed cannabidiol (“CBD”) and placebo materials for its upcoming U.S. phase 1b hypertension clinical trial HYPER-H23-1. According to the update, Lexaria retained the services of a U.S. contract manufacturing organization to produce the materials compliant with current Good Manufacturing Practice (“cGMP”) regulations as mandated by the Food and Drug Administration (“FDA”). Filling into capsules is expected to be completed this month. This will follow with analytical release and stability testing in order to gather essential quality control data necessary for…

WednesdayMay 10, 2023 2:29 pm

CannabisNewsBreaks – Lift 2023 Event to Return to the Heart of Downtown Toronto

Lift Events & Experiences, Canada’s No. 1 cannabis conference and trade show series, today announced its return to the Metro Toronto Convention Centre (“MTCC”), a top-of-class venue for business event organizers, located in the heart of downtown Toronto. Lift Toronto 2023, slated to take place on June 1-3, is expected to attract representatives from more than 150 companies within the cannabis-value chain, 140+ renowned industry thought leaders, and 3,000 to 5,000 growers, licensed producers, retailers, budtenders, investors and consumers. As a fifth year of cannabis legalization in Canada comes to fruition, the event will commence with the full-day Lift Cannabis…

WednesdayMay 10, 2023 2:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at 1:00 p.m. PT on May 9, 2023, whereby there were 3,372,024 shares of the company represented in person or by proxy, constituting 56.3% of the company's issued share capital as of the meeting date of March 13, 2023. The matters voted upon and the final voting results are set forth as detailed in the announcement. All proposals are described in detail in Lexaria’s proxy statement filed with the Securities…

TuesdayMay 09, 2023 1:40 pm

CannabisNewsBreaks – Alternative Products Expo Slated to Return to Medellín for Upcoming Two-Day Event

The Alternative Products Expo, produced by ZJ Events, is being held this year for two days in Medellín, Colombia. Slated for May 20–21, 2023, the conference will feature an estimated 200 companies exhibiting more than 1,000 products in the alternative products space. Medellín, which hosted the expo in 2017 as well, offers an ideal location for the conference, which is designed to provide attendees with key information from the alternative-products space as well as invaluable networking opportunities. The event has become the largest expo series for all things vape, hemp and counterculture, and is a key gathering for smoke-shop owners,…

MondayMay 08, 2023 3:04 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery…

FridayMay 05, 2023 10:43 am

CannabisNewsBreaks – BizCann Expo Shares Agenda Details for Upcoming Colombian Cannabis Expo

BizCann Expo, hosted by ZJ Events, is gearing up for its next event to be held May 21–22, 2023, in Medellín, Colombia. A premier cannabis event in South and Latin America, BizCann is designed to provide key information on innovation, entrepreneurship, and education on all aspects of the cannabis sector. This year’s two-day agenda features an impressive array of presentations from more than 20 speakers, including 3C Consulting founder and CEO Nic Easley, GNC-Brands founder Juan Gonzalez, Global Cannabis Network Collective business developer Rosa Maria Puentes Velosa and Green Leaf Colombia cofounder and production manager Camilo Martínez. The event is…

WednesdayMay 03, 2023 2:01 pm

CannabisNewsBreaks — AROYA Notes Anniversary of Nonprofit Freedom Grams, Celebrates Growing Awareness of Initiative

AROYA, a division of ADDIUM Inc., is noting the one-year anniversary of nonprofit cannabis brand, Freedom Grams. The brand was created by a coalition of AROYA, retailer and manufacturer GABY Inc. and nonprofit Last Prisoner Project. According to the announcement, Freedom Grams has become a strong advocate for the release of more than 40,000 people in the United States who are still Incarcerated for nonviolent cannabis possession. Initially launched through California-based dispensary Mankind, Freedom Grams and its initiative has spread to additional locations and states and now has more than 60 retail partners. AROYA announced that, following 4/20, the biggest day…

WednesdayMay 03, 2023 1:49 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) GrowPods Ideal Options for Academic Research, Education

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, is announcing that its modular hydroponic farms are available for research and educational purposes. The company observed that its GrowPods offer the perfect environment for college and university studies and research focused on controlled environment agriculture (“CEA”) and farming. According to the announcement, universities are at the “forefront of innovation” with many institutions opening or expanding their agricultural departments with CEA farms. As examples, the company cited Auburn University’s focus on improving vegetable production in CEA, Purdue University’s creation of an entire department dedicated…

MondayApr 24, 2023 1:29 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards CRO Contract for Upcoming Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it awarded the contract for clinical research organization (“CRO”) services to California-based InClin, Inc. for its expected upcoming Food and Drug Administration (“FDA”)-registered, U.S. phase 1b Investigational New Drug (“IND”) hypertension study HYPER-H23-1 with its patented DehydraTECH-powered cannabidiol (“DehydraTECH-CBD”). According to the announcement, HYPER-H23-1 is entitled “A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of DehydraTECH-CBD in Subjects with Stage 1 or Stage 2 Hypertension.” The study’s primary objective will be to evaluate safety and tolerability in 120 hypertensive patients,…

ThursdayApr 20, 2023 10:49 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expanding Portfolio with Four New Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has received notifications of four new patents either awarded or allowed. In Japan, the company secured a new patent under its Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents. This is Lexaria’s fifth awarded patent in Japan, providing strength to its growing Japanese patent portfolio. In Australia, Lexaria has received a new patent under its Patent Family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents. This is Lexaria’s 10th patent in Australia and its second in this patent family.…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks